Ernexa Therapeutics (ERNA) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q2 2025
Q4 2025
Q2 2026
-6.95
-4.84
-2.72
-0.61

Details

Expected EPS
-1.95
Actual EPS
-6.95
Surprise EPS
-5
Surprise Percent
+256.41%

Description

Ernexa Therapeutics (ERNA) has reported earnings of -6.95 per share for Q2 2026.

0 Comments

Share your thoughts